Abiopharma

🔍 Scannell Timothy J (Director)

Company: MASIMO CORP (MASI)

Report Date: 2026-04-23

Detailed Transactions and Holdings:

• Acquired 1,225 shares of Common Stock (Direct)
  Date: 2026-04-29 | Code: M | equity_swap_involved: 0 | shares_owned_after: 2,608.00 | transaction_form_type: 4
• Sold 1,225 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-29 | Code: M | Expires: 2035-04-29 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F2
• Acquired 1,119 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-23 | Code: A | Expires: 2036-04-23 | equity_swap_involved: 0 | shares_owned_after: 2,238.00 | transaction_form_type: 4 | Footnotes: F1, F3

Footnotes:

• F1: Each restricted stock unit (RSU) represents the contingent right to receive one share of common stock of the Issuer upon vesting of the RSU.
• F2: These RSUs were granted on April 29, 2025 and will vest in full on the earlier of the first anniversary of the grant date or the date of the next annual meeting of stockholders following the date of grant.
• F3: These RSUs were granted on April 23, 2026 and will vest in full on the earlier of the first anniversary of the grant date or the date of the next annual meeting of stockholders following the date of grant.